Patents Examined by Ivan Greene
-
Patent number: 9271494Abstract: The present invention relates to shelf stable and/or less corrosive peroxycarboxylic acid antimicrobial compositions, including ready-to-use compositions. Shelf stable compositions can include defined ratios of hydrogen peroxide to peroxycarboxylic acid and/or hydrogen peroxide to protonated carboxylic acid, but need not include strong acid. Reduced corrosion compositions can include carboxylic acid and corrosion inhibitor at acid pH. Compositions of the invention can have advantageous activity against spores.Type: GrantFiled: August 30, 2007Date of Patent: March 1, 2016Assignee: Ecolab USA, Inc.Inventors: Daniel E. Pedersen, Katherine Joan Molinaro, Michael Besse
-
Patent number: 9241913Abstract: Gel nanoparticles for encapsulating and delivering a pharmaceutical compound to a patient. The nanoparticles are formed from N-trimethyl chitosan and polysialic acid, preferably in the presence of sodium tripolyphosphate. A ratio of polysialic acid to N-trimethyl chitosan of about 0.5 to 1 produces nanoparticles having diameter of about 100 nm (plus or minus 25 nm) and a zeta potential above 30 milivolts that can stability contain a pharmaceutical compound, such as methotrexate, for delivery to a patient.Type: GrantFiled: May 18, 2012Date of Patent: January 26, 2016Assignee: Syracuse UniversityInventor: Rebecca A. Bader
-
Patent number: 9193654Abstract: Cosmetic bases consisting of alkylene oxide derivatives represented by the general formula (I): Z—{O(AO)l(EO)m—(BO)nH}a(I) wherein Z is a residue derived from a compound having three to nine hydroxyl groups by the removal of the hydroxyl groups; a is 3 to 9; AO is C3-4 oxyalkylone; EO is oxyethylene; l and m represent the average numbers of added C3-4 oxyalkylene molecules and oxyalkylene molecules respectively and satisfy the relationships: 1?1?50 and l?m?50 respectively; the AO/EO weight ratio is 1/5 to 5/1 and AO's and EO's may be added at random or in block; BO is oxyalkylene having 4 carbon atoms; and n represents the average number of added BO molecules and satisfies the relationship: 0.5?n?5.Type: GrantFiled: October 6, 2005Date of Patent: November 24, 2015Assignee: NOF CORPORATIONInventors: Kei-ichi Maruyama, Yoji Tezuka
-
Patent number: 9095513Abstract: The present invention is an enteric coated granule having controlled dissolution in water even at a small coating amount; and a preparation method thereof.Type: GrantFiled: June 15, 2007Date of Patent: August 4, 2015Assignee: Shin-Etsu Chemical Co., Ltd.Inventors: Mutsunori Tanji, Tadashi Matsui, Shuichiro Yuasa, Yuichi Nishiyama, Yuichi Ito, Ikuo Fukui
-
Patent number: 9084436Abstract: The present invention relates to a method for providing a fiber-containing pectin product from a plant material. The method comprises the steps of: (i) providing a plant material comprising pectin, where said pectin is having a degree of esterification of 55% or less, (ii) adding an acidic aqueous solution to the pectin containing plant material obtained in step (i) and providing a suspension of the plant material, where the suspended plant material provides an in situ system by swelling the plant material under conditions where the pectin is kept within the plant material, and (iii) obtaining the fiber-containing pectin product from the suspension provided in step (ii), wherein the plant material is substantially depleted from divalent cations.Type: GrantFiled: August 29, 2008Date of Patent: July 21, 2015Assignee: KMC Kartoffelmelcentralen AMBAInventors: Ole Bandsholm Sørensen, Peter Fromholt Larsen
-
Patent number: 9056089Abstract: The present invention discloses a process of preparing jambu extract that results in a jambu extract free from chlorophyll and derivatives of this compound. It is a method for isolating the components of interest in a simplified way, with quite high process yield, higher than 85%. The present invention further relates to the use of this extract in preparing cosmetic compositions, the cosmetic compositions comprising said extract, and to cosmetic products comprising said cosmetic compositions.Type: GrantFiled: March 21, 2006Date of Patent: June 16, 2015Assignee: Natura Cosmeticos S.A.Inventors: Sergio Delarcina, Jr., José Renato Cagnon, Alexandre Roberto Silva, Viviane Emi Nakano Fukusawa
-
Patent number: 9006281Abstract: The present disclosure is directed to compounds and methods for treating irritable bowel syndrome, chronic kidney disease and end stage renal disease by administering to a subject in need thereof a compound or a pharmaceutically acceptable salt thereof, wherein the compound has the structureType: GrantFiled: March 14, 2013Date of Patent: April 14, 2015Assignee: Ardelyx, Inc.Inventors: Noah Bell, Christopher Carreras, Dominique Charmot, Jeffrey W Jacobs, Michael Robert Leadbetter, Marc Navre
-
Patent number: 8980226Abstract: A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of fosfomycin plus tobramycin is able to inhibit susceptible bacteria. Fosfomycin and tobramycin are formulated separately in a dual ampoule such that when reconstituted, the pH is between 4.5 and 8.0 or as a dry powder. The method for treatment of respiratory tract infections by a formulation delivered as an aerosol having mass median aerodynamic diameter predominantly between 1 to 5?, produced by a jet or ultrasonic nebulizer (or equivalent) or dry powder inhaler.Type: GrantFiled: September 14, 2012Date of Patent: March 17, 2015Assignee: Gilead Sciences, Inc.Inventors: William Baker, David MacLeod
-
Patent number: 8969377Abstract: The present disclosure is directed to compounds of the structure (X): wherein: n is 2 or 3; NHE has the structure wherein: R1 is H or —SO2—NR7R8—; R2 is selected from H, —NR7(CO)R8, —SO2—NR7R8— and —NR7R8; R3 is hydrogen; R7 is hydrogen; R8 is a bond linking to L; L is a polyalkylene glycol linker; and Core has the following structure: wherein: X is selected from the group consisting of a bond, —O—, —NH—, NHC(?O)—, —NHC(?O)NH— and —NHSO2—; and Y is selected from the group consisting of a bond, optionally substituted C1-6 alkylene, optionally substituted benzene, pyridinyl, a polyethylene glycol linker and —(CH2)1-6O(CH2)1-6—, and methods of using such compounds for the treatment of irritable bowel syndrome, chronic kidney disease and end-stage renal disease.Type: GrantFiled: March 14, 2013Date of Patent: March 3, 2015Assignee: Ardelyx, Inc.Inventors: Noah Bell, Christopher Carreras, Dominique Charmot, Jeffrey W Jacobs, Michael Robert Leadbetter, Marc Navre
-
Patent number: 8962023Abstract: A method of UV curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of UV light in both intensity and duration to achieve a desired amount of cross-linking forming the gel.Type: GrantFiled: September 28, 2005Date of Patent: February 24, 2015Assignee: Atrium Medical CorporationInventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Thomas M. Swanick
-
Patent number: 8951567Abstract: Discrete microstructures of predefined size and shape are prepared using sol-gel phase-reversible hydrogel templates. An aqueous solution of hydrogel-forming material is covered onto a microfabricated silicon wafer master template having predefined microfeatures, such as pillars. A hydrogel template is formed, usually by lowering the temperature, and the formed hydrogel template is peeled away from the silicon master template. The wells of predefined size and shape on the hydrogel template are filled with a solution or a paste of a water-insoluble polymer, and the solvent is removed to form solid structures. The formed microstructures are released from the hydrogel template by simply melting the hydrogel template in water. The microstructures are collected by centrifugation. The microstructures fabricated by this method exhibit pre-defined size and shape that exactly correspond to the microwells of the hydrogel template.Type: GrantFiled: September 27, 2008Date of Patent: February 10, 2015Assignee: Akina, Inc.Inventors: Kinam Park, Ghanashyam Acharya, Haesun Park
-
Patent number: 8945598Abstract: The present invention relates to a process for reducing solvent contents in drug-containing polymeric compositions. Specifically, the solvent contents in the drug-containing polymeric compositions are first reduced by one or more conventional drying methods, to a range from about 0.5 wt % to about 10 wt % of the total weight of the polymeric composition. Subsequently, the drug-containing polymeric compositions are further treated by one or more low temperature (i.e., having processing temperatures of less than 60° C.) drying methods for further reduction of the solvent content to less than 10,000 ppm.Type: GrantFiled: December 29, 2005Date of Patent: February 3, 2015Inventors: Vipul Dave, Murty N. Vyakamam, Qiang Zhang
-
Patent number: 8916196Abstract: The apparatus and methods of the present invention are of use for the production of emulsion-based microparticles containing a biological or chemical agent. In particular, the apparatus provides a vessel; packing material situated inside such vessel and may further provide material capable of insertion into both ends of said vessel for enclosure of the packing material. In a particular embodiment, the apparatus is a packed bed apparatus. The methods include production of emulsion based microparticles containing a biological or chemical agent. The usefulness of the present invention is that the apparatus and methods of the present invention provide for a low-shear, non-turbulent, production of emulsion-based microparticles that provides a narrow, reproducible, particle size distribution, capable of use with both large and small volumes that is capable of being conveniently scaled up while providing predictable emulsion properties.Type: GrantFiled: April 12, 2004Date of Patent: December 23, 2014Assignee: Evonik CorporationInventor: Ehud Zeigerson
-
Patent number: 8747885Abstract: The present invention provides to patches having excellent skin-permeability and therapeutic effect by the drug with lower irritation. In an external patch in which an adhesive layer containing an adhesive base and a drug are laminated with a backing, the external patch wherein the adhesive base contains 5-50% by weight of synthetic rubber polymer, 10-60% by weight of adhesive resin and 25-60% by weight of liquid paraffin, and the drug is etofenamate. According to the present invention, there is obtainable the patches having excellent skin-permeability and therapeutic effect by the drug with lower irritation.Type: GrantFiled: December 15, 2004Date of Patent: June 10, 2014Assignees: Teikoku Seiyaku Co., Ltd., Drossapharm AGInventors: Tomohiro Ishima, Hiroyuki Yamasaki, Masahiro Yamaji
-
Patent number: 8715708Abstract: A novel class of Cylic Acetal biomaterials (CABs) based on a cyclic acetal unit is disclosed and claimed by Applicants. Two novel biomaterials suitable for use in a variety of biological applications including in the orthopedic field for joint and cartilage replacement and/or repair, and bone cement. The biomaterials are comprised of either a network of monomers of 5-ethyl-5-(hydroxymethyl)-?,?-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and a hydrogel comprised of EHD and poly(ethylene glycol) diacrylate (PEG-EHD).Type: GrantFiled: August 31, 2006Date of Patent: May 6, 2014Assignee: University of MarylandInventors: John Patrick Fisher, Sachiko Kaihara, Jennifer Lynn Moreau, Parth Modi
-
Patent number: 8609141Abstract: The present invention pertains to silver ion bearing carriers useful in treating monorrhagia of a mammalian uterus, comprising a physiologically inert, flexible earner, e.g., a coil, bearing a tissue cauterizing amount of a silver ion. Silver ions are delivered to the endometrium and cause necrosis of the endometrial tissue. The silver ions remaining within the uterine cavity can then be neutralized with a sodium chloride solution delivered to the uterus e.g., by catheter, and the carrier recovered from the uterus.Type: GrantFiled: September 1, 2009Date of Patent: December 17, 2013Assignee: Ablation Products LLCInventor: Robert S. Neuwirth
-
Patent number: 8603499Abstract: The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries.Type: GrantFiled: May 10, 2013Date of Patent: December 10, 2013Assignee: BIND Therapeutics, Inc.Inventors: Stephen E. Zale, Mir Mukkaram Ali
-
Patent number: 8603500Abstract: The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries.Type: GrantFiled: May 10, 2013Date of Patent: December 10, 2013Assignee: BIND Therapeutics, Inc.Inventors: Stephen E. Zale, Mir Mukkaram Ali
-
Patent number: 8603501Abstract: The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries.Type: GrantFiled: May 10, 2013Date of Patent: December 10, 2013Assignee: BIND Therapeutics, Inc.Inventors: Stephen E. Zale, Mir Mukkaram Ali
-
Patent number: 8541448Abstract: The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.Type: GrantFiled: June 29, 2011Date of Patent: September 24, 2013Assignee: Ardelyx, Inc.Inventors: Dominique Charmot, Jeffrey W. Jacobs, Michael Robert Leadbetter, Marc Navre, Christopher Carreras, Noah Bell